VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WALD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WALDWaldencast plc
$1.46$173M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksWALDFinancials

Waldencast plc (WALD) Financials

6Y historyFree accessUpdated daily

Revenue growth has stalled to -1.7% in 2025Q4, while gross margins have compressed to 43.9%, reflecting significant challenges in maintaining profitability within the competitive beauty sector.

WALD Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricDec'25Dec'24Dec'23Dec'22Dec'21Dec'20
Sales/Revenue272.07M273.87M218.14M166.13M142.47M94.43M
Revenue Growth %-0.66%25.55%31.3%16.61%50.88%-
Cost of Goods Sold148.24M82.12M76.56M126.7M55.04M29.1M
COGS % of Revenue54.48%29.99%35.1%76.26%38.63%30.81%
Gross Profit123.83M131.73M141.58M39.44M87.44M65.33M
Gross Margin %45.52%48.1%64.9%23.74%61.37%69.19%
Gross Profit Growth %-5.99%-6.96%259%-54.9%33.83%-
Operating Expenses185.51M185.28M223.51M113.7M89.06M64.8M
OpEx % of Revenue68.18%67.65%102.46%68.44%62.51%68.63%
Selling, General & Admin185.51M245.3M220.31M109.3M71.62M60.42M
SG&A % of Revenue68.18%89.57%101%65.79%50.27%63.99%
Research & Development003.19M4.4M6.09M4.38M
R&D % of Revenue--1.46%2.65%4.28%4.64%
Other Operating Expenses0-60.02M0011.35M0
Operating Income-61.67M-58.58M-81.93M-74.27M-1.63M528K
Operating Margin %-22.67%-21.39%-37.56%-44.7%-1.14%0.56%
Operating Income Growth %-5.28%28.5%-10.32%-4470.4%-407.77%-
EBITDA-2.49M1.43M-21.43M-39.1M12.28M13.95M
EBITDA Margin %-0.92%0.52%-9.83%-23.53%8.62%14.77%
EBITDA Growth %-274.07%106.68%45.18%-418.41%-11.97%-
D&A (Non-Cash Add-back)59.18M60.02M60.5M35.17M13.9M13.42M
EBIT-61.67M-31.38M-94.04M-134.42M1.14M517K
Net Interest Income-25.09M-17.16M-18.91M-12.87M-11.12M-6.28M
Interest Income00012.88K00
Interest Expense25.09M17.16M18.91M12.88M11.12M6.28M
Other Income/Expense-200.57M5.01M-31.01M-73.03M-8.35M-6.29M
Pretax Income-262.25M-48.54M-112.94M-147.3M-9.97M-5.76M
Pretax Margin %-96.39%-17.72%-51.78%-88.67%-7%-6.1%
Income Tax-14.19M110K-6.97M-5.69M9.6M-3.39M
Effective Tax Rate %5.41%-0.23%6.18%3.86%-96.27%58.88%
Net Income-229.75M-42.44M-89.98M-116.62M-19.58M-2.37M
Net Margin %-84.44%-15.5%-41.25%-70.2%-13.74%-2.51%
Net Income Growth %-441.31%52.83%22.85%-495.75%-725.99%-
Net Income (Continuing)-248.06M-48.65M-105.97M-141.61M-19.58M-2.37M
Discontinued Operations000000
Minority Interest38.22M67.62M144.65M160.66M00
EPS (Diluted)-2.01-0.39-0.89-1.08-0.45-0.20
EPS Growth %-415.38%56.18%17.59%-140%-125%-
EPS (Basic)-2.01-0.39-0.89-1.08-0.45-0.20
Diluted Shares Outstanding114.07M109.3M101.23M107.56M43.71M11.68M
Basic Shares Outstanding114.07M109.3M101.23M107.56M43.71M11.68M
Dividend Payout Ratio------

Key Metrics

Growth RegimeDecelerating
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Persistent Operating Margin Deficit

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2025Q4)

Revenue Growth Stalls Amid Saturation

According to recent financial filings, Waldencast's revenue growth has decelerated to -1.7% in 2025Q4, marking a significant reversal from the double-digit expansion observed in previous periods and suggesting that the company's core brand portfolio is struggling to maintain market share in a competitive beauty landscape.

The transition from 30.8% growth in 2024Q4 to negative territory indicates that the initial post-acquisition momentum has dissipated. Investors should monitor whether this contraction reflects broader channel saturation or a failure of recent product launches to resonate with the target consumer base.

Structural Margin Erosion Remains Concerning

As reported in quarterly statements, the company's gross margin compressed to 43.9% in 2025Q4, a notable decline from the 60-70% range typically expected in prestige beauty, which may indicate persistent inventory inefficiencies or an over-reliance on promotional discounting to drive sell-through at major retail partners.

This margin profile appears structurally inferior to peers like e.l.f. Beauty, suggesting that Waldencast lacks the pricing power necessary to offset rising input costs. The inability to sustain higher gross margins implies that the current business model may be fundamentally misaligned with the cost structure of the prestige skincare market.

Operating Leverage Remains Elusive Platform

Based on the provided income statement data, Waldencast continues to report significant operating losses, with SG&A expenses of $91.7M in 2025Q4 consistently outpacing gross profit, demonstrating a failure to achieve the necessary scale to cover the fixed overhead of its corporate platform and professional sales infrastructure.

The persistent negative operating margin of -21.7% suggests that the company is not yet benefiting from operational synergies between its Obagi and Milk Makeup segments. Without a clear path to rationalizing SG&A, the company remains highly vulnerable to further earnings dilution.

Sustainability of Current Operating Model

Data from recent filings reveals a net margin of -43.1% in 2025Q4, which highlights the severe risk that the company's current cost structure is unsustainable, potentially forcing management to choose between aggressive capital raises or significant asset divestitures to preserve liquidity in the coming fiscal year.

Short-sellers would likely focus on the widening gap between revenue and operating expenses, which suggests that the platform's value proposition is not translating into bottom-line results. The lack of R&D investment in recent quarters may also indicate a short-term focus on survival at the expense of long-term brand innovation.

WALD — Frequently Asked Questions

Quick answers to the most common questions about buying WALD stock.

What was Waldencast plc's (WALD) revenue in 2025?

For fiscal year 2025, Waldencast plc (WALD) reported total revenue of $272.1M. This represents a 188.1% increase compared to $94.4M in 2020.

Is Waldencast plc (WALD) profitable?

Waldencast plc (WALD) reported a net loss of $229.7M for the fiscal year ending 2025.

What is Waldencast plc's operating profit margin?

Waldencast plc (WALD) reported an operating income of $-61.7M, resulting in an operating profit margin of -22.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Waldencast plc's gross profit and gross margin?

Waldencast plc (WALD) generated $123.8M in gross profit for the year, representing a gross profit margin of 45.5%. This demonstrates the company's core pricing power and production efficiency.